Clinical Trial Update: Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab [Phase 2]

View source ↗

Summary

Phase 2 trial of efalizumab for beta cell rescue in new-onset type 1 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Raptiva (efalizumab)

Snippet

Sponsor: Emory University | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: WITHDRAWN